Entresto
Novartis sues U.S. government over IRA price negotiations for Entresto
Anika Sharma
Novartis has taken legal action against the U.S. government in response to the Inflation Reduction Act (IRA), becoming the latest ...
Regulatory Authority Raises Concerns Over Novartis’ Entresto Podcast Marketing Assertions
SG Tylor
Novartis, a trailblazer in digital pharma innovation for years, now faces the intricate labyrinth of regulatory compliance. This complex challenge ...
Novartis Announces Strong Revenue Growth, Share Buyback, and Sandoz Separation
SG Tylor
Source – Novartis Novartis, a pharmaceutical company, has announced a new $15 billion stock repurchase plan after completing a previous ...
Novartis to Appeal Court Decision on Entresto Combination Patent; Confirms 2023 Guidance and Mid-Term Outlook
SG Tylor
Source: Novartis On July 7, 2023, Novartis received a negative decision from the US District Court regarding the validity of ...
